The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.
Switzerland was hit with a 39% tariff rate by the US this month, far higher than the 15% levied on the neighboring European Union. Pharmaceuticals are currently exempt from Donald Trump’s tariffs, but that might soon change, with the president warning he could announce measures on the sector.